Skip to content

Álvaro París

3 papers in the library · publishing 2023-2025

Papers

Sort Most recent Most cited

Tackling the growing burden of nitrous oxide-induced public health harms.

The Lancet Public Health February 1, 2025 Safiya A Zaloum, Devan Mair, Álvaro París et al.

Nitrous oxide has been increasing in popularity as a recreational drug in the past decade, and with this an increase in health harms related to nitrous oxide use, particularly nitrous oxide-induced myeloneuropathy. In response, governments in many countries have adopted new laws that either target the end user, by criminalising possession, or target suppliers. The effect of these measures...

Nitrous oxide-induced myeloneuropathy: a case series

Journal of Neurology, Neurosurgery, and Psychiatry May 30, 2023 Devan Mair, Álvaro París, Safiya A Zaloum et al.

Background Nitrous oxide (N2O) is the second most common recreational drug used by 16- to 24-year-olds in the UK. Neurological symptoms can occur in some people that use N2O recreationally, but most information comes from small case series. Methods We describe 119 patients with N2O-myeloneuropathy seen at NHS teaching hospitals in three of the UK’s largest cities: London, Birmingham and...

Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment

Practical Neurology February 22, 2023 Álvaro París, Luke Lake, Albert Joseph et al.

Recreational use of nitrous oxide (N2O) has increased rapidly in recent years and is now the second most commonly used recreational drug among young people in the UK. There has been a corresponding rise in cases of nitrous oxide-induced subacute combined degeneration of the cord (N2O-SACD), a pattern of myeloneuropathy usually associated with severe vitamin B12 deficiency. This can cause...